Toggle Navigation

Gynuity staff present on postpartum hemorrhage diagnosis & management at upcoming EBCOG Congress

26th European Board & College of Obstetrics and Gynaecology (EBCOG) Congress
March 8-10, 2018 │ Palais des Congrès de Paris │ Paris, France

New Evidence and Innovations in PPH Diagnosis and Management
Friday, March 9, 2018 | 13:45 – 15:15 | Bordeaux Amphitheater

FIGO and Gynuity Health Projects invite you to join us for a scientific session that includes presentations of new evidence on PPH diagnosis and management followed by a Q&A. 
Session Chair: Prof Sir Sabaratnam Arulkumaran, past RCOG and FIGO president

Time to rethink how we diagnose and treat PPH? The role of shock index
Beverly Winikoff, President, Gynuity Health Projects

Expanding options for PPH management at all levels of care: The role of misoprostol and condom uterine balloon tamponade
Rasha Dabash, Senior Director, Gynuity Health Projects

Adding tranexamic acid (TXA) to the arsenal of interventions: The WOMAN trial results
Haleema Shakur-Still, Associate Professor, LSHTM

Full details about the EBCOG congress can be found here.

TelAbortion study featured in Cosmopolitan

Gynuity’s innovative study on telemedicine* provision of medical abortion is featured in the March 2018 issue of Cosmopolitan. The article, “Abortion’s Next Frontier: Video Chat”, is available digitally here.

The TelAbortion study evaluates the use of telemedicine for providing a medical abortion to women who may have difficulty getting to a clinic where abortion is provided. The time, travel costs, lost wages, and childcare arrangements involved in accessing this basic reproductive right can be a substantial hardship for many women in the United States. Even though millions of women have used abortion pills, and their safety is well-established, the medications are not available in pharmacies (even with a prescription) and instead must be obtained directly from providers. Through the TelAbortion study, women receive the medications by mail and are followed by their providers remotely.

For more information about this study, please visit

[*Telemedicine is the remote delivery of health care services and clinical information using a variety of telecommunications including phone, video, and the internet.]

Telabortion project referenced in Chicago Tribune

Gynuity’s innovative new study on telemedicine provision of abortion was featured in the Chicago Tribune article, entitled "On the anniversary of Roe v. Wade, a look at the future of pill-induced abortion". The study is evaluating the safety, acceptability and feasibility of the service, which aims to increase access to women who may have difficulty getting to an abortion clinic. 

For more information about this study, please visit

Gynuity Health Project’s E-news bulletin

Gynuity Health Project's E-news bulletin shares information about the work of our staff and collaborators in the field. We report on recent and upcoming meetings, highlights of new and ongoing projects, recently published articles and materials, and some of our key achievements. We will also have a "Spotlight on..." feature in each newsletter providing an in-depth look at a specific project.

Click here to view our April 2017 E-news bulletin
Click here to view our September 2017 E-news bulletin

Expanding Healthcare Worker Roles in Abortion Care

Please join us for a Webinar hosted by the Supporting Expanded Roles for Abortion services by Healthcare workers (SERAH) working group 

Thursday, 18 January 2018 
10am EST / 12pm ART / 3pm GMT / 4pm CET / 6pm EAT / 8:45pm NPT

Register here to join the webinar: ">

To increase safe abortion access and mitigate global shortages in abortion health care providers, the World Health Organization (WHO) recently published the evidence-based guideline, Health worker roles in providing safe abortion care and post-abortion contraception, which offers a range of options and recommendations for task-sharing safe abortion care, including the provision of abortion methods, management of abortion complications, and the provision of post-abortion contraception. Based on review of the global evidence, these guidelines recommend a number of tasks that mid-level providers, including midwives, nurses, community health workers, and pharmacists, among others, and women themselves can safely and effectively offer. 

The SERAH working group was formed in December 2015 to facilitate a coordinated approach towards moving these guideline recommendations into policy and practice at the country level. SERAH includes representatives from Department for Reproductive Health and Research at WHO, the International Federation of Gynecology and Obstetrics (FIGO), Gynuity Health Projects, Ibis Reproductive Health, International Campaign for Women’s Right to Safe Abortion, International Confederation of Midwives (ICM), International Planned Parenthood Federation (IPPF), Ipas Global, London School of Hygiene and Tropical Medicine (LSHTM), Marie Stopes International (MSI), Pathfinder International, and Population Studies International (PSI).  

During this webinar Dr Bela Ganatra (RHR/WHO) will highlight the key features of the WHO guideline and four panelists will offer illustrative country experiences with task-sharing in abortion care in Colombia, Ethiopia, Kyrgyzstan, and Nepal. Discussions will be followed by Q and A from Webinar participants. The webinar will be chaired by two representatives from SERAH. 

Bela Ganatra, Department of Reproductive Health and Research, WHO
Dr. Bela Ganatra, a physician and behavioural scientist by training is currently the technical lead for the work on preventing unsafe abortion at the Department of Reproductive Health and Research at the World Health Organisation, Geneva. The department’s current work on the topic includes development of global normative guidance on clinical service delivery and policy issues, monitoring global trends in abortion safety, conducting relevant research and providing technical support to countries. She was closely involved with the development of the guideline on health worker roles in safe abortion care and post-abortion contraception.


  • Gunta Lazdane, Prof Reproductive Health, Director of the Public Health Institute, Riga Stradins University, Latvia; ex-Programme Manager Sexual and Reproductive Health, WHO Regional office for Europe

Gunta Lazdane is an obstetrician and gynaecologist and Ph.D. From 2003 to 2017 she was working in the WHO Regional Office for Europe as a Programme Manager, Sexual and Reproductive Health in the Division of Noncommunicable Diseases and Promoting Health through the Life-course. She was assisting 53 WHO Member States in the European Region to improve sexual, reproductive, maternal and newborn health through promoting good health at key stages of life, improving quality of health care, taking into account the need to address social determinants of health and gender, equity and human rights. Dr. Lazdane has participated in many European and global conferences and congresses including International Conference on Population and Development in Cairo in 1994 and the Fourth World Conference on Women, Beijing 1995. She was the Chief Editor of the European Magazine for Sexual and Reproductive Health Entre Nous. Since 2017 she is a Professor Reproductive Health and a Director of the Public Health Institute in the Riga Stradins University, Latvia and continuous to share her experience with students and her peers in Latvia and other countries. 

  • Kidest Lulu Hagos, Deputy Country Director, Pathfinder International Ethiopia

Kidest Lulu Hagos is a medical doctor with public health specialty, working for Pathfinder Ethiopia as a Technical Director and Deputy Country Director. Her previous experiences include working as a general practitioner in District and Referral Hospitals, as an Assistant Professor of Public Health in Jimma University. She has served in the field of FP/RH for the past 13 years in different international organizations also including USAID- Ethiopia; The Millennium Villages Project - The Earth Institute at Columbia University; and WHO Ethiopia. Kidest is very passionate about improving the lives of Ethiopian women through betterment of access and quality of SRH services, ensuring women’s equality and fighting for the abolishment of harmful traditional practices. 

  • Swaraj Rajbhandari, Senior Ob/Gyn & Senior MNCH Advisor, Nepal

Dr. Swaraj Rajbhandari is an OB/GYN and has worked extensively in implementation of quality reproductive health services all around the world. She is a founding member and past-President of NESOG and of the Menopause Society of Nepal. She played a vital role in establishing PAC services in Fiji, Malawi, Myanmar and Nepal. She provided technical assistance to the Government of Cambodia to expand Safe Abortion services along with long term family planning services through a DFID funded program. She is a Master Trainer in Reproductive Health, Emergency Obstetrics & Neonatal Care, Post-Abortion Care, Comprehensive Abortion Care, Long Term Family Planning methods, and VSC procedures. She is currently working as a Senior Consultant at NIDAN Hospital in Nepal and is a team leader of M4 Health to improve quality is services in maternal and neonatal health. 

  • María Vivas, Deputy Director, Oriéntame/ESAR Foundations, Colombia

Dr. Maria Vivas is a medical doctor trained in Bogotá, Colombia, and holds a Master's in Public Health with a focus in epidemiology from the University of California in Berkeley, California.  As a bilingual doctor who specialized in public health, she has experience working in international environments in different aspects of program implementation and research projects in sexual and reproductive health, health disparities, maternal-infant health, and access to primary healthcare. Her work has always been embedded in the understanding of social determinants of health, finding creative solutions to increase access to primary health care services while maintaining high quality standards, especially within groups who are disproportionately stricken by healthcare inequalities. Currently, as the Deputy director of Oriéntame Clinics and the ESAR Foundation, Dr. Vivas is part of a team that has had an essential role increasing access to safe abortion practices in Colombia and the treatment of incomplete abortion in other restrictive contexts.  She supports the executive director in the development and implementation of strategic plans and policies for both intuitions. Prior to this role, she monitored project activities proposed to decrease unwanted pregnancies in countries where ESAR/Oriéntame is present. She served as a Public Health Medical Specialist with Oriéntame designing activities that increased coverage and access to services that contributed to the comprehensive management of unwanted pregnancies.  Dr. Vivas also worked at the University of California in the USA as the Director of Research Projects, a Postgraduate Researcher, and Analyst and Data Manager Supervisor of the Women's Global Health Imperative, and at the Hospital Rafael Uribe in Colombia as a Coordinator of Public Health Programs. 


  • Rasha Dabash, Senior Director, Gynuity Health Projects
  • Annik Sorhaindo, Consultant, Department of Reproductive Health and Research, WHO